By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Reviva Pharmaceuticals Inc. 

5941 Optical Court

San Jose  California  95138  U.S.A.
Phone: 1-408-960-2209 Fax: 1-408-960-2206



Company News
Reviva Pharma Announces Addition Of A New Member To Its Board Of Directors 7/24/2017 8:16:09 AM
Reviva Pharma Announces Closing Of Bridge Financing And Addition Of A New Member To Its Board Of Directors 5/22/2017 11:14:23 AM
Reviva Pharma Receives FDA Orphan Designation For Pulmonary Arterial Hypertension (PAH) 11/17/2016 8:08:17 AM
Reviva Pharma Presented RP5063 Preclinical Efficacy Results For Pulmonary Arterial Hypertension At American Thoracic Society Conference 2016 5/20/2016 10:20:07 AM
Reviva Pharmaceuticals Inc Reports RP5063 Positive Efficacy Results For Memory Deficits 10/22/2015 11:36:42 AM
Reviva Pharmaceuticals Inc Appoints Three New Board Members 3/11/2015 10:53:33 AM
Reviva Pharmaceuticals Inc Wins 2014 TiE50 Award 5/19/2014 8:50:50 AM
Reviva Pharmaceuticals Inc Announces Successful End-of-Phase 2 Meeting With FDA for RP5063 11/5/2013 7:14:49 AM
Reviva Pharmaceuticals Inc Reports Positive Top-Line Results From a Phase 2 Clinical Trial of RP5063 for the Treatment of Schizophrenia and Schizoaffective Disorder 4/10/2013 12:08:29 PM
Schizophrenia Drug Startup Reviva Pharmaceuticals Inc Raises $12 Million 3/22/2013 8:01:17 AM